PEDF Attenuates Insulin-dependent Molecular Pathways of Glucose Homeostasis in Skeletal Myocytes
Overview
Endocrinology
Molecular Biology
Affiliations
Pigment epithelium-derived factor (PEDF) is an anti-angiogenic serpin associated with insulin resistance in metabolic disorders such as diabetes, metabolic syndrome, obesity and polycystic ovarian syndrome. While the mechanism of PEDF induced-insulin resistance of metabolic disorders has been attributed to its inflammatory and lipolytic effects, little evidence exists to support a direct role of PEDF in mediating insulin resistance. Here, we seminally provide evidence that PEDF can inhibit insulin signal transduction governing glucose homeostasis from the receptor to the effector phosphorylation through Akt/PKB-dependent and -independent pathways in mouse and human skeletal muscle cell lines. PEDF attenuates the insulin-dependent molecular axes of glucose metabolism. Exposure of skeletal myocytes to PEDF attenuates insulin-dependent insulin receptor autophosphorylation, tyrosine phosphorylation of insulin receptor substrate 1, and dual loop phosphorylation-activation of Akt. PEDF significantly inhibits the downstream effector - glycogen synthase kinase (and thereby the glycogenic axis of insulin signalling). PEDF turned off both the molecular switches of GLUT4 translocation: IRS-Akt/PKB-AS160 mediated and IR-pCbl-dependent GLUT4 translocation (the molecular axis of glucose uptake). These findings implicate a direct effect of PEDF on multiple insulin-dependent molecular mechanisms of glucose homeostasis in skeletal muscle cells, thereby enabling it to contribute to peripheral insulin resistance at the cellular level.
Characteristics of changes in plasma proteome profiling after sleeve gastrectomy.
Zhang Y, Shi C, Wu H, Yan H, Xia M, Jiao H Front Endocrinol (Lausanne). 2024; 15:1330139.
PMID: 38375199 PMC: 10875463. DOI: 10.3389/fendo.2024.1330139.
The interplay between the muscle and liver in the regulation of glucolipid metabolism.
Chen C, Xie L, Zhang M, Shama , Cheng K, Jia W J Mol Cell Biol. 2023; 15(12).
PMID: 38095440 PMC: 11078061. DOI: 10.1093/jmcb/mjad073.
Jones I, Carnagarin R, Armstrong J, Lin D, Baxter-Holland M, Elahy M Pharmaceutics. 2023; 15(7).
PMID: 37514146 PMC: 10384968. DOI: 10.3390/pharmaceutics15071960.
Li L, Cao X, Huang L, Huang X, Gu J, Yu X J Cell Mol Med. 2023; 27(10):1327-1340.
PMID: 37070131 PMC: 10183704. DOI: 10.1111/jcmm.17730.
Yao Y, Tian S, Li N, Yang Y, Zhang C Front Nutr. 2022; 9:1017072.
PMID: 36245495 PMC: 9562104. DOI: 10.3389/fnut.2022.1017072.